JNK1 Protein

JNK1 Protein — c-Jun N-terminal Kinase 1

Overview

Jnk1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

JNK1 (c-Jun N-terminal Kinase 1), encoded by the MAPK8 gene, is a member of the MAPK family that functions as a central regulator of cellular stress responses. JNK1 is activated by various cellular stresses including oxidative stress, inflammatory cytokines, excitotoxicity, and protein aggregation. In [neurons](/entities/neurons), JNK1 plays complex roles in both adaptive stress responses and pathological cell death pathways. Chronic or excessive JNK1 activation contributes to neurodegeneration in Alzheimer's disease, Parkinson's disease, stroke, and traumatic brain injury, making JNK1 signaling an important therapeutic target. [@jnka]

...

JNK1 Protein — c-Jun N-terminal Kinase 1

Overview

Jnk1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

JNK1 (c-Jun N-terminal Kinase 1), encoded by the MAPK8 gene, is a member of the MAPK family that functions as a central regulator of cellular stress responses. JNK1 is activated by various cellular stresses including oxidative stress, inflammatory cytokines, excitotoxicity, and protein aggregation. In [neurons](/entities/neurons), JNK1 plays complex roles in both adaptive stress responses and pathological cell death pathways. Chronic or excessive JNK1 activation contributes to neurodegeneration in Alzheimer's disease, Parkinson's disease, stroke, and traumatic brain injury, making JNK1 signaling an important therapeutic target. [@jnka]

<div class="infobox infobox-protein"> [@jnkb]
<table> [@jnkc]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">c-Jun N-terminal Kinase 1</th></tr> [@jnkd]
<tr><td><strong>Protein Name</strong></td><td>Mitogen-Activated Protein Kinase 8 (MAPK8)</td></tr> [@jnke]
<tr><td><strong>Gene Name</strong></td><td>MAPK8</td></tr> [@jnkf]
<tr><td><strong>Alternative Names</strong></td><td>JNK1, SAPK1, Stress-Activated Protein Kinase 1</td></tr> [@djnki]
<tr><td><strong>UniProt ID</strong></td><td>[P45985](https://www.uniprot.org/uniprot/P45985)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>46 kDa (isoform dependent)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm, nucleus (upon activation)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>MAPK family (CMGC group)</td></tr>
<tr><td><strong>PDB Structures</parameter></td><td>1UKH, 2XR7, 4H39, 6SX6</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>10q11.22</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">105 edges</a></td>
</tr>
</table>
</div>

Isoforms and Splice Variants

JNK1 is expressed as multiple isoforms generated by alternative splicing:

JNK1 Isoforms

• JNK1α1: 46 kDa, widely expressed
• JNK1α2: 46 kDa, alternative C-terminus
• JNK1β1/β2: Extended isoforms with distinct tissue distribution

The α and β isoforms differ in their C-terminal regions, affecting substrate specificity and localization.

Activation Mechanism

Upstream Activation Cascade

JNK1 is activated through a canonical MAPK cascade:

MAPKKK activation: MEKK1-4, MLK3, TAK1

MAPKK activation: MKK4 (SEK1), MKK7

JNK activation: Dual phosphorylation on Thr183 and Tyr185

Activation Triggers

JNK1 is activated by various cellular stresses:

| Stress Type | Activating Signals | Pathophysiological Context |
|-------------|-------------------|---------------------------|
| Oxidative stress | [ROS](/entities/reactive-oxygen-species), lipid peroxidation | Aging, neurodegeneration |
| Inflammatory cytokines | TNF-α, IL-1β, IL-6 | Neuroinflammation |
| Excitotoxicity | Glutamate, [NMDA receptor](/entities/nmda-receptor) overactivation | Stroke, TBI |
| DNA damage | UV radiation, genotoxic agents | Cellular stress |
| Protein aggregation | Misfolded proteins | AD, PD, ALS |

Negative Regulation

JNK1 activity is tightly regulated:

• MAPK phosphatases (MKPs): DUSP1, DUSP10, DUSP16
• Inactivating phosphatases: [PP2A](/entities/pp2a), PP1
• Scaffold proteins: JIP1, JIP2, JIP3
• Feedback inhibition: By phosphorylated substrates

Substrates and Biological Functions

Transcriptional Targets

JNK1 phosphorylates multiple transcription factors:

• c-Jun: AP-1 component, promotes pro-apoptotic gene expression
• JunD: Context-dependent pro- or anti-apoptotic
• ATF2: Stress-responsive transcription factor
• NFAT4: Calcium-dependent transcription
• p53: Tumor suppressor, stress response

Non-Transcriptional Targets

JNK1 also acts on non-nuclear substrates:

• Mitochondrial proteins: Bcl-2 family, cytochrome c
• Cytoskeletal proteins: [Tau](/proteins/tau), MAPs
• Synaptic proteins: Synapsin, PSD-95
• Other kinases: ASK1, MKK4

Role in Neuronal Survival and Death

Dual Roles in Neuronal Biology

JNK1 has context-dependent effects:

Pro-survival functions:

• Acute stress response and adaptation
• Developmental cell death pruning
• Synaptic plasticity regulation

Pro-death functions:

• Chronic stress-induced [apoptosis](/entities/apoptosis)
• Excitotoxic cell death
• [Neuroinflammation](/mechanisms/neuroinflammation)mediated damage

Apoptosis Mechanisms

JNK1 promotes neuronal apoptosis through:

Mitochondrial pathway: Phosphorylates Bim, promotes Bax activation

Transcriptional activation: c-Jun-mediated pro-apoptotic gene expression

ER stress: Activates CHOP pathway

Synaptic dysfunction: Contributes to synaptic loss

Role in Alzheimer's Disease

JNK1 is hyperactivated in Alzheimer's disease brain:

Amyloid-beta Pathogenesis

JNK1 mediates [Aβ](/proteins/amyloid-beta)-induced neuronal damage:

• Aβ activates JNK1: Via NMDA receptor and ROS generation
• Tau phosphorylation: JNK1 phosphorylates tau at multiple sites
• Synaptic dysfunction: Contributes to synaptic loss
• Neuronal death: Mediates excitotoxic and oxidative damage

Tau Pathology

JNK1 contributes to tau hyperphosphorylation:

• Direct phosphorylation: JNK1 phosphorylates tau at Thr181, Ser202, Thr205
• Kinase activation: Links Aβ to tau pathology
• Therapeutic target: JNK inhibition reduces tau pathology

Neuroinflammation

JNK1 drives neuroinflammation in AD:

• Glial activation: Regulates microglial and astrocyte responses
• Cytokine production: Promotes TNF-α, IL-1β, IL-6 release
• Cyclooxygenase-2: Induces COX-2 expression

Role in Parkinson's Disease

JNK1 is critically involved in PD pathogenesis:

Dopaminergic Neuron Vulnerability

JNK1 contributes to dopaminergic neuron death:

• Oxidative stress: Activated by ROS in substantia nigra
• MPTP/MPP+ toxicity: Mediates MPTP-induced degeneration
• 6-OHDA model: JNK activation in lesion models
• Genetic susceptibility: JNK pathway genes linked to PD risk

Alpha-synuclein Aggregation

JNK1 interacts with [α-synuclein](/proteins/alpha-synuclein) pathology:

• Phosphorylation: JNK1 can phosphorylate α-synuclein
• Aggregation modulation: Affects fibril formation
• Cellular toxicity: Contributes to dopaminergic dysfunction

Mitochondrial Dysfunction

JNK1 affects mitochondrial quality control:

• PINK1/Parkin pathway: Modulates mitophagy
• Mitochondrial permeability: Promotes cytochrome c release
• Energy crisis: Contributes to ATP depletion

Therapeutic Implications

JNK inhibitors are being developed for PD:

• SP600125: Research JNK inhibitor, neuroprotective in models
• D-JNKI1: Cell-penetrating JNK inhibitor, in clinical trials
• AS601245: Anti-inflammatory JNK inhibitor

Role in Stroke and Brain Injury

JNK1 contributes to ischemic brain damage:

Ischemic Stroke

JNK1 activation following cerebral ischemia:

• Reperfusion injury: ROS triggers JNK activation
• Excitotoxicity: Glutamate release activates JNK
• Infarct expansion: JNK mediates secondary damage
• Therapeutic window: JNK inhibition provides neuroprotection

Traumatic Brain Injury

JNK1 contributes to post-traumatic neurodegeneration:

• Primary injury: Mechanical damage activates JNK
• Secondary injury: Inflammation and edema
• Long-term outcomes: Chronic JNK activation affects recovery

Role in Other Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis

• SOD1 mutations: JNK activation in mutant SOD1 models
• [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology: JNK responds to proteostatic stress
• Motor neuron death: Contributes to disease progression

Huntington's Disease

• Mutant [huntingtin](/proteins/huntingtin): Activates JNK pathway
• Transcriptional dysregulation: c-Jun targets affected
• Therapeutic potential: JNK inhibition beneficial in models

Therapeutic Targeting

JNK Inhibitors in Development

| Compound | Selectivity | Development Stage | Notes |
|----------|-------------|-------------------|-------|
| SP600125 | Pan-JNK | Research tool | Anthrapyrazolone |
| D-JNKI1 | Pan-JNK | Clinical trials | Cell-penetrating peptide |
| AS601245 | Pan-JNK | Preclinical | Anti-inflammatory |
| CC-930 | JNK1/2 | Clinical trials | For kidney disease |
| IQ-1S | JNK1/2 | Research | C-Jun inhibitor |

Challenges

• Pan-JNK inhibition: Effects on JNK2/3, which may have different roles
• [BBB](/entities/blood-brain-barrier) penetration: Ensuring CNS delivery
• Therapeutic window: Timing of intervention
• Adaptive vs. maladaptive JNK: Distinguishing beneficial from harmful activation

Key Publications

[JNK signaling in neurodegeneration - Nat Rev Neurosci 2008](https://pubmed.ncbi.nlm.nih.gov/18695001/)

[JNK1 in Alzheimer's disease - J Neurosci 2010](https://pubmed.ncbi.nlm.nih.gov/20844124/)

[JNK and neuronal death - Cell Death Differ 2006](https://pubmed.ncbi.nlm.nih.gov/16337599/)

[JNK in Parkinson's disease - Mov Disord 2022](https://pubmed.ncbi.nlm.nih.gov/35102684/)

[JNK inhibitors for stroke - Neurobiol Dis 2019](https://pubmed.ncbi.nlm.nih.gov/30826573/)

[JNK and tau pathology - J Neurochem 2021](https://pubmed.ncbi.nlm.nih.gov/34478521/)

See Also

• [MAPK8 Gene](/genes/mapk8)
• [JNK2 Protein](/proteins/jnk2-protein)
• [JNK3 Protein](/proteins/jnk3-protein)
• [MKK4 Protein](/proteins/mkk4-protein)
• [MKK7 Protein](/proteins/mkk7-protein)
• [c-Jun Protein](/proteins/c-jun-protein)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Stroke](/diseases/stroke)
• [Excitotoxicity](/mechanisms/excitotoxicity)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [JNK Inhibitors](/therapeutics/jnk-inhibitors)

Overview

Jnk1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Jnk1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Unknown, JNK signaling in neurodegeneration - Nat Rev Neurosci (n.d.)](https://pubmed.ncbi.nlm.nih.gov/18695001/)

[Unknown, JNK1 in Alzheimer's disease - J Neurosci (n.d.)](https://pubmed.ncbi.nlm.nih.gov/20844124/)

[Unknown, JNK and neuronal death - Cell Death Differ (n.d.)](https://pubmed.ncbi.nlm.nih.gov/16337599/)

[Unknown, JNK in Parkinson's disease - Mov Disord (n.d.)](https://pubmed.ncbi.nlm.nih.gov/35102684/)

[Unknown, JNK1 in tau phosphorylation - J Biol Chem (n.d.)](https://pubmed.ncbi.nlm.nih.gov/10608846/)

[Unknown, JNK inhibitors for stroke - Neurobiol Dis (n.d.)](https://pubmed.ncbi.nlm.nih.gov/30826573/)

[Unknown, JNK pathway in ALS - Exp Neurol (n.d.)](https://pubmed.ncbi.nlm.nih.gov/22609142/)

[Unknown, D-JNKI1 neuroprotection - Proc Natl Acad Sci (n.d.)](https://pubmed.ncbi.nlm.nih.gov/12766227/)